Loading...
XCSESTENO
Market cap3mUSD
Dec 23, Last price  
1.32DKK
1D
1.54%
1Q
-42.11%
IPO
-96.28%
Name

Stenocare A/S

Chart & Performance

D1W1MN
XCSE:STENO chart
P/E
P/S
7.02
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
6.74%
Rev. gr., 5y
-1.94%
Revenues
4m
-16.30%
4,144,8138,784,408198,4501,575,0004,489,5813,757,828
Net income
-18m
L+7.77%
-3,276,2931,702,421-11,786,282-12,732,465-16,303,170-17,569,552
CFO
-10m
L-33.21%
-5,574,453-2,544,598-12,702,984-13,343,589-15,032,657-10,040,864

Profile

Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
IPO date
Oct 26, 2018
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
3,758
-16.30%
4,490
185.05%
1,575
693.65%
Cost of revenue
10,178
10,899
15,653
Unusual Expense (Income)
NOPBT
(6,420)
(6,410)
(14,078)
NOPBT Margin
Operating Taxes
(1,253)
(1,584)
(1,527)
Tax Rate
NOPAT
(5,167)
(4,825)
(12,551)
Net income
(17,570)
7.77%
(16,303)
28.04%
(12,732)
8.03%
Dividends
Dividend yield
Proceeds from repurchase of equity
17,896
BB yield
-50.53%
Debt
Debt current
8,746
6,102
255
Long-term debt
2,311
6,479
2,231
Deferred revenue
Other long-term liabilities
1,053
315
Net debt
1,559
8,151
(9,235)
Cash flow
Cash from operating activities
(10,041)
(15,033)
(13,344)
CAPEX
(176)
(936)
(3,270)
Cash from investing activities
(177)
(937)
(2,539)
Cash from financing activities
15,287
8,679
1,243
FCF
492
(6,391)
(15,502)
Balance
Cash
9,498
4,429
11,720
Long term investments
Excess cash
9,311
4,205
11,641
Stockholders' equity
25,822
24,143
40,243
Invested Capital
26,194
31,889
30,159
ROIC
ROCE
EV
Common stock shares outstanding
13,944
12,099
12,088
Price
2.54
-72.36%
9.19
-11.12%
10.34
-47.35%
Market cap
35,418
-68.15%
111,193
-11.04%
124,986
-42.92%
EV
36,977
119,344
115,751
EBITDA
(3,036)
(3,097)
(12,991)
EV/EBITDA
Interest
2,876
1,295
213
Interest/NOPBT